References
- Szarewski A, Mansour D, Shulman L. 50 years of ‘The Pill’: celebrating a golden anniversary J. Fam. Plann. Reprod. Health Care36(4), 231–238 (2010).
- Shapiro S, Dinger J. Risk of venous thromboembolism among users of oral contraceptives. A review of two recently published studies. J. Fam. Plann. Reprod. Health Care36(1), 33–38 (2010).
- Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br. J. Haematol.139, 289–296 (2007).
- Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am. J. Hematol.83, 97–102 (2008).
- Heinemann K, Heinemann LAJ. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel. J. Fam. Plann. Reprod. Health Care37, 132–135 (2011).
- Reid RL, Westhoff C, Mansour D et al. Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009. J. Fam. Plann. Reprod. Health Care36(3), 117–122 (2010).
- Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception75(5), 344–354 (2007).
- Heinemann LA, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women Contraception75, 328–336 (2007).
- Seeger JD, Williams PL, Walker AM. An application of propensity score matching using claims data. Pharmacoepidemiol. Drug Safety14(7), 465–476 (2005).
- Dinger J, Assmann A, Mohner S, Minh TD. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case–control study. J. Fam. Plann. Reprod. Health Care36(3), 123–129 (2010).
- Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet353, 1167–1173 (1999).
- Chan KT, Tye GA, Popat RA et al. Common iliac vein stenosis: a risk factor for oral contraceptive-induced deep vein thrombosis. Am. J. Obstet. Gynecol. DOI: 10.1016/j.ajog.2011.06.100 (2011) (Epub ahead of print).
- Szarewski A, Mansour D. The pill and thrombosis: study subject to unmeasured confounders and biases BMJ342, d3349 (2011).
- Parkin L, Sharples K, Hernandez RK, Jick S. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ342, d2139 (2011).
- Panay N. Management of premenstrual syndrome. J. Fam. Plann. Reprod. Health Care35(3), 187–194 (2009).
- Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ339, b2890 (2009).
- Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J. Clin. Epidemiol.63, 223–228 (2010).
Website
- MHRA: Drug Safety Update, 4(11), A2 (2011) www.mhra.gov.uk/home/groups/dsu/documents/publication/con120237.pdf